Roswtha Verwer explores how delayed diagnosis in reproductive health drives emotional, financial, and clinical costs, and how earlier biological insight can reduce failed fertility cycles and unnecessary escalation.

Roswitha Verwer shares why YON E is closing its seed readiness round, how funding will support prototype completion, clinical trial preparation, regulatory readiness, and the next phase of women’s health diagnostics.

YON E is preparing for launch by listening first. Through voice-of-customer research with 400+ women, clinician conversations, community engagement, and pricing validation, we are building a women’s health platform rooted in real demand, clinical relevance, and objective daily insights into cycle, fertility, and vaginal health.

Roswitha Verwer explores why women’s health remains reactive and symptom-based, and how continuous physiological signals like temperature and vaginal health can provide real insight. Understanding patterns over time enables better fertility awareness, earlier intervention, and more informed care decisions.

Trust is not a feature in women’s health; it is the foundation.

This article explores why transparency, data ownership, and clinical integrity are essential for adoption in femtech. Discover how YON E is redefining women’s health technology by prioritizing safety, clarity, and user control, because without trust, even the most advanced solutions fail.

Preventive women’s health is entering a new era.

Roswitha Verwer explains how biosensors, personalized medicine, and cultural change are making hormonal and reproductive health measurable, empowering women and clinicians with data-driven insights.

Integrity in women’s healthcare is not a marketing choice; it is a responsibility.

In this powerful reflection, Roswitha Verwer shares why transparency, honesty, and moral clarity must define FemTech innovation and leadership, and how YON E is setting a new standard for trust, data ethics, and women-centered care.

Roswitha Verwer explains why women’s health technology must put values before profit.

Discover how trust, empowerment, and inclusive design are reshaping femtech and improving healthcare outcomes for women.

Femtech adoption depends on trust and emotional safety, not only clinical validation. This article shows how UX design, branding, and patient experience influence engagement in vaginal health and fertility tech.

Women’s bodies weren’t the standard in medical research and women’s health still pays the price. This article explains how male-default clinical trials drive misdiagnosis and uneven drug response, and why femtech + inclusive health data can enable personalized care.

This article explains why trust is the missing infrastructure in women’s health: femtech must prioritize ongoing consent and data transparency so women feel safe to engage and research can finally improve care and pharma outcomes.

Women’s health innovation must start with real life, not labs. This article explores why listening to women, tracking real biomarkers, and breaking taboos is essential for preventive, science based care and better clinical outcomes.